Clinical trials demonstrate that these medications deliver impressive results: They help people with type 2 diabetes achieve A1C reductions of 1.5-2.0% Most people lose 10-15% of their body weight (thats 20-30 pounds for someone weighing 200 pounds) Cardiovascular outcomes improve significantly Insulin sensitivity increases by 25-40% However, success brings new questions
eating smaller meals throughout the day avoids becoming too full, which may reduce nausea and other gastrointestinal adverse effects
In the ELIXA [66], EXSCEL [68], and PIONEER 6 [67,71] studies, treatments of exenatide twice-daily, exenatide once-weekly, and oral semaglutide groups were non-inferior to placebo in terms of CV disease safety, respectively
These data elucidate the effects of morroniside on HF development and growth
The liposomal technology used in this formulation protects the L-Carnitine molecules and enables better absorption in the small intestine